HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CF PHARMTECH

6.055

+0.3055.30%

Volume:10.32M

Turnover:63.21M

Market Cap:2.62B

PE:917.42

High:6.430

Open:5.750

Low:5.575

Close:5.750

52wk High:41.840

52wk Low:5.175

Shares:432.00M

HK Float Shares:323.00M

Volume Ratio:1.86

T/O Rate:3.19%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.007

ROE:0.21%

ROA:-0.83%

PB:1.66

PE(LYR):917.42

PS:5.11

Loading ...

Overview Company News Filings

CF Pharmtech files HKEX next-day disclosure return reporting share repurchase at HKD 19.14-high HKD 18.52-low

CF PharmTech Clears GMP Inspection for Suzhou Inhalation Drug Facility

MT Newswires Live

CF PharmTech’s Suzhou Inhalation Facility Passes PIC/S GMP Inspection, Unlocking New International Market Potential

Bulletin Express

CF PHARMTECH Facility Passes Key International Pharmaceutical Inspection

CF PHARMTECH Executes Share Buyback, Spending HK$684.3k

CF PHARMTECH Shares Surge Over 5% on Regulatory Green Light for New Drug Trial

CF PharmTech Monthly Return: 551,000 H-Share Repurchase Pushes Treasury Stock to 1.22 Million

Bulletin Express

CF PharmTech Sets 26 June AGM to Approve 2025 Results, Board Refresh, H-Share Incentive Expansion and Dual Capital Mandates

Bulletin Express

CF PHARMTECH (02652) Announces NMPA Approval for ICF004 Investigational New Drug Application

CF Pharmtech - Nmpa Approves Ind Application for ICF004 as Class 1 New Drug

THOMSON REUTERS

CF PharmTech Updates Board Structure and Committee Line-up

Bulletin Express

CF PHARMTECH (02652) Announces Proposed Nomination of Zhang Jingjing as Executive Director

CF Pharmtech files directors list with Hong Kong Stock Exchange

CF PharmTech non-executive director Chen Penghui resigns effective May 29, 2026

CF Pharmtech Inc - to Nominate Zhang Jingjing as Candidate for Executive Director

THOMSON REUTERS

CF PharmTech Repurchases 64,500 H Shares for HKD 1.29 Million, Lifts Treasury Stock to 1.17 Million

Bulletin Express

CF PHARMTECH (02652) Executed HK$1.29 Million Share Buyback on May 28

CF PharmTech Files Southeast Asia Marketing Authorization Application for Inhalation Drug; Shares Up 4%

MT Newswires Live

CF PHARMTECH (02652): CF017 Submits Marketing Authorization Application in Southeast Asia

CF PharmTech files for Southeast Asian approval of inhaled budesonide CF017, advancing global commercialization strategy

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/02652/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"CF PHARMTECH","latestPrice":6.055,"timestamp":1791533288003,"preClose":5.75,"halted":0,"volume":10319300,"delay":0,"changeRate":0.05304347826086952,"floatShares":323000000,"shares":432000000,"eps":0.0066,"marketStatus":"Closed","change":0.305,"latestTime":"10-09 16:08:08","open":5.75,"high":6.43,"low":5.575,"amount":63206271,"amplitude":0.148696,"askPrice":6.075,"askSize":500,"bidPrice":6.055,"bidSize":2200,"shortable":3,"etf":0,"ttmEps":-0.018,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791768600000},"marketStatusCode":5,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":5.75,"openAndCloseTimeList":[[1791509400000,1791518400000],[1791522000000,1791532800000]],"volumeRatio":1.856623,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":323000000,"roa":"-0.83%","roe":"0.21%","lyrEps":0.0066,"volumeRatio":1.856623,"shares":432000000,"dividePrice":0,"high":6.43,"amplitude":0.148696,"preClose":5.75,"low":5.575,"week52Low":5.175,"pbRate":"1.66","psRate":"5.11","week52High":41.84,"institutionHeld":0,"latestPrice":6.055,"committee":0.62963,"eps":0.0066,"divideRate":0,"volume":10319300,"delay":0,"ttmEps":-0.018,"open":5.75,"prevYearClose":35,"prevWeekClose":6.85,"prevMonthClose":6.935,"prevQuarterClose":6.935,"fiveDayClose":6.85,"twentyDayClose":9.6,"sixtyDayClose":16.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"date":"2026-03-30","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2026-10-08","current":-336.388889,"percent":0.106122,"low":-715.224392,"twenty":386.814037,"median":480.920419,"eighty":2721.065475,"high":3595.964728,"avg":1274.248545,"sd":1275.259692,"marketCap":2336583725},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106},{"date":"2025-10-31","current":411.638127,"twenty":385.87135,"median":395.798507,"eighty":410.009732,"marketCap":12482945126},{"date":"2025-11-07","current":380.629431,"twenty":385.87135,"median":397.412529,"eighty":410.009732,"marketCap":11535394836},{"date":"2025-11-14","current":413.442652,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"marketCap":12565340803},{"date":"2025-11-21","current":474.663516,"twenty":387.596392,"median":401.654037,"eighty":419.1227,"marketCap":14419243545},{"date":"2025-11-28","current":513.213561,"twenty":390.697015,"median":408.734506,"eighty":451.19497,"marketCap":15646939138},{"date":"2025-12-05","current":509.365027,"twenty":391.797785,"median":411.605323,"eighty":487.699676,"marketCap":15556303893},{"date":"2025-12-12","current":478.26383,"twenty":394.588712,"median":413.442652,"eighty":485.541496,"marketCap":14633472306},{"date":"2025-12-19","current":468.273561,"twenty":396.041553,"median":429.606948,"eighty":482.974301,"marketCap":14361566570},{"date":"2025-12-24","current":469.497744,"twenty":396.770692,"median":439.211078,"eighty":482.563912,"marketCap":14443962248},{"date":"2026-01-02","current":452.984556,"twenty":397.492287,"median":451.385447,"eighty":481.570975,"marketCap":13990786022},{"date":"2026-01-09","current":417.797013,"twenty":398.674444,"median":438.955991,"eighty":480.057858,"marketCap":12936121351},{"date":"2026-01-16","current":442.060347,"twenty":399.985866,"median":432.778937,"eighty":478.730146,"marketCap":13731858722},{"date":"2026-01-23","current":466.639698,"twenty":400.772068,"median":439.902936,"eighty":477.371374,"marketCap":14481468286},{"date":"2026-01-30","current":480.840623,"twenty":401.791027,"median":446.916666,"eighty":477.757159,"marketCap":14990389486},{"date":"2026-02-06","current":464.022312,"twenty":403.190746,"median":452.185001,"eighty":477.033593,"marketCap":14502764350},{"date":"2026-02-13","current":452.173894,"twenty":406.744138,"median":454.320794,"eighty":475.6532,"marketCap":14213623359},{"date":"2026-02-20","current":472.094804,"twenty":408.734506,"median":454.916554,"eighty":476.776403,"marketCap":14818441932},{"date":"2026-02-27","current":505.751529,"twenty":411.273773,"median":459.838493,"eighty":479.42962,"marketCap":16048983093},{"date":"2026-03-06","current":445.246344,"twenty":411.572519,"median":460.887466,"eighty":481.94993,"marketCap":14015073071},{"date":"2026-03-13","current":299.287031,"twenty":402.338985,"median":457.528006,"eighty":481.000215,"marketCap":9464083401},{"date":"2026-03-20","current":315.053976,"twenty":397.81132,"median":454.320794,"eighty":480.840623,"marketCap":9924943114},{"date":"2026-03-27","current":299.095644,"twenty":391.175665,"median":451.779671,"eighty":479.42962,"marketCap":9398246299},{"date":"2026-04-02","current":3318.248683,"twenty":389.832113,"median":451.779671,"eighty":480.872541,"marketCap":9381570423},{"date":"2026-04-10","current":3321.445916,"twenty":390.816678,"median":452.984556,"eighty":482.236241,"marketCap":9463036901},{"date":"2026-04-17","current":3317.060015,"twenty":392.419904,"median":455.282385,"eighty":483.410603,"marketCap":9454509433},{"date":"2026-04-24","current":2996.4431,"twenty":394.891161,"median":460.26919,"eighty":490.336167,"marketCap":8541149514},{"date":"2026-04-30","current":3202.871531,"twenty":396.041553,"median":462.144769,"eighty":499.979081,"marketCap":9131900891},{"date":"2026-05-08","current":3148.404437,"twenty":397.173254,"median":463.774025,"eighty":508.169798,"marketCap":9007763175},{"date":"2026-05-15","current":2973.181714,"twenty":398.099028,"median":464.50673,"eighty":512.854422,"marketCap":8528814526},{"date":"2026-05-22","current":2811.882705,"twenty":399.495195,"median":466.720409,"eighty":2921.871357,"marketCap":8047680823},{"date":"2026-05-29","current":3180.044455,"twenty":400.476536,"median":467.247998,"eighty":2926.706614,"marketCap":9133017429},{"date":"2026-06-05","current":2895.334441,"twenty":400.969089,"median":468.273561,"eighty":2926.706614,"marketCap":8327404730},{"date":"2026-06-12","current":2591.262092,"twenty":402.338985,"median":469.314298,"eighty":2919.612019,"marketCap":7447807192},{"date":"2026-06-18","current":2679.987141,"twenty":403.474666,"median":471.144686,"eighty":2910.923271,"marketCap":7719084937},{"date":"2026-06-26","current":2653.65777,"twenty":407.739322,"median":472.774581,"eighty":2903.774482,"marketCap":7608107678},{"date":"2026-07-03","current":2674.595079,"twenty":410.258066,"median":474.904398,"eighty":2905.018632,"marketCap":7673871980},{"date":"2026-07-10","current":2510.065653,"twenty":411.453021,"median":477.841604,"eighty":2898.212797,"marketCap":7192970522},{"date":"2026-07-17","current":2212.458756,"twenty":411.611884,"median":479.42962,"eighty":2892.703479,"marketCap":6362696210},{"date":"2026-07-24","current":2249.530522,"twenty":411.787912,"median":481.475073,"eighty":2888.435745,"marketCap":6470762659},{"date":"2026-07-31","current":2830.800739,"twenty":412.509722,"median":482.52515,"eighty":2884.270453,"marketCap":8158252159},{"date":"2026-08-07","current":2582.169982,"twenty":413.490204,"median":483.399827,"eighty":2872.355071,"marketCap":7456157987},{"date":"2026-08-14","current":2399.972298,"twenty":415.255724,"median":487.118208,"eighty":2848.370255,"marketCap":6938825440},{"date":"2026-08-21","current":2153.795127,"twenty":418.883405,"median":491.347467,"eighty":2826.107192,"marketCap":6240837082},{"date":"2026-08-28","current":2055.558094,"twenty":420.751477,"median":499.411825,"eighty":2817.123583,"marketCap":5957535925},{"date":"2026-09-04","current":-569.998069,"twenty":413.490204,"median":496.308733,"eighty":2813.278273,"marketCap":4516395257},{"date":"2026-09-11","current":-530.602158,"twenty":411.393271,"median":488.453269,"eighty":2785.197315,"marketCap":4209914329},{"date":"2026-09-18","current":-562.645514,"twenty":401.517047,"median":483.417787,"eighty":2737.610634,"marketCap":4469986257},{"date":"2026-09-25","current":-486.336524,"twenty":397.332771,"median":482.867142,"eighty":2725.301169,"marketCap":3856379052},{"date":"2026-10-02","current":-350.674033,"twenty":391.797785,"median":482.188522,"eighty":2723.288145,"marketCap":2783582350},{"date":"2026-10-08","current":-293.99455,"twenty":386.814037,"median":480.920419,"eighty":2721.065475,"marketCap":2336583725}],"updateTime":1791550019892},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642467642","title":"CF Pharmtech files HKEX next-day disclosure return reporting share repurchase at HKD 19.14-high HKD 18.52-low","url":"https://stock-news.laohu8.com/highlight/detail?id=2642467642","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642467642?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:08","pubTimestamp":1781006932,"startTime":"0","endTime":"0","summary":"CF Pharmtech repurchased 31,000 H shares on June 9 for treasury, no shares cancelled.Buyback price range HKD 18.52 to HKD 19.14; aggregate consideration HKD 586,055.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL7wRHDs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641194425","title":"CF PharmTech Clears GMP Inspection for Suzhou Inhalation Drug Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2641194425","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641194425?lang=en_us&edition=fundamental","pubTime":"2026-06-05 12:23","pubTimestamp":1780633427,"startTime":"0","endTime":"0","summary":"CF PharmTech  said its inhalation formulation production base in Suzhou passed a good manufacturing practice inspection conducted by the drug regulator of a member country of the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme, according to a Thursday Hong Kong bourse filing.The inspection covered the facility's production management and quality control systems, premises, equipment, data integrity, and computerized systems.Shares of the pharmaceutical firm were up over 1% in Friday morning trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0345781412.USD","LU0345780950.USD","LU0630314457.HKD","02652","BK4585","BK4588","BK4093","CF","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110397613","title":"CF PharmTech’s Suzhou Inhalation Facility Passes PIC/S GMP Inspection, Unlocking New International Market Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1110397613","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110397613?lang=en_us&edition=fundamental","pubTime":"2026-06-04 21:24","pubTimestamp":1780579454,"startTime":"0","endTime":"0","summary":"CF PharmTech (02652) announced that its inhalation formulation production base in Suzhou has successfully passed an on-site Good Manufacturing Practice (GMP) inspection conducted by the drug...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153622309","title":"CF PHARMTECH Facility Passes Key International Pharmaceutical Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=1153622309","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153622309?lang=en_us&edition=fundamental","pubTime":"2026-06-04 21:22","pubTimestamp":1780579349,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that its inhalation drug production facility located in Suzhou, China, has successfully passed an on-site Good Manufacturing Practice (GMP) compliance inspection...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153929970","title":"CF PHARMTECH Executes Share Buyback, Spending HK$684.3k","url":"https://stock-news.laohu8.com/highlight/detail?id=1153929970","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153929970?lang=en_us&edition=fundamental","pubTime":"2026-06-04 21:06","pubTimestamp":1780578409,"startTime":"0","endTime":"0","summary":"On June 4, 2026, CF PHARMTECH (02652) announced it had repurchased 33,500 of its own shares.The total expenditure for this buyback transaction amounted to approximately HK$684,300.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159731974","title":"CF PHARMTECH Shares Surge Over 5% on Regulatory Green Light for New Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1159731974","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159731974?lang=en_us&edition=fundamental","pubTime":"2026-06-04 14:30","pubTimestamp":1780554629,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (SEHK: 02652) shares climbed more than 5% in trading. At the time of writing, the stock was up 5.55% to HK$21.3, with a turnover of HK$5.66 million.The recent price movement follows...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","BK4585","02652","VXUS","BK1191","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149956112","title":"CF PharmTech Monthly Return: 551,000 H-Share Repurchase Pushes Treasury Stock to 1.22 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1149956112","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149956112?lang=en_us&edition=fundamental","pubTime":"2026-06-03 17:05","pubTimestamp":1780477545,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. submitted its Monthly Return for the period ended 31 May 2026 to Hong Kong Exchanges and Clearing Limited on 03 June 2026. • Registered capital remained unchanged at 411.98 million...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174360035","title":"CF PharmTech Sets 26 June AGM to Approve 2025 Results, Board Refresh, H-Share Incentive Expansion and Dual Capital Mandates","url":"https://stock-news.laohu8.com/highlight/detail?id=1174360035","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174360035?lang=en_us&edition=fundamental","pubTime":"2026-06-02 23:03","pubTimestamp":1780412602,"startTime":"0","endTime":"0","summary":"CF PharmTech will convene its annual general meeting (AGM) on 26 June 2026 in Suzhou to seek shareholder approval on nine key resolutions that shape its next operating cycle and capital strategy. Key...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122546310","title":"CF PHARMTECH (02652) Announces NMPA Approval for ICF004 Investigational New Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1122546310","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122546310?lang=en_us&edition=fundamental","pubTime":"2026-06-01 08:10","pubTimestamp":1780272631,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that the Investigational New Drug (IND) application for ICF004 inhalation powder, a Class I new drug, has recently been approved by China's National Medical...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640989785","title":"CF Pharmtech - Nmpa Approves Ind Application for ICF004 as Class 1 New Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2640989785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640989785?lang=en_us&edition=fundamental","pubTime":"2026-06-01 08:00","pubTimestamp":1780272038,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN42800I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175962402","title":"CF PharmTech Updates Board Structure and Committee Line-up","url":"https://stock-news.laohu8.com/highlight/detail?id=1175962402","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175962402?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:23","pubTimestamp":1780064609,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. released an announcement on 29 May 2026 detailing the latest composition of its Board of Directors and the three principal Board committees. The Board now comprises ten members....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159833172","title":"CF PHARMTECH (02652) Announces Proposed Nomination of Zhang Jingjing as Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1159833172","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159833172?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:20","pubTimestamp":1780064419,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that Mr. Chen Penghui has resigned from his position as a non-executive director, effective May 29, 2026, due to his desire to dedicate more time to other...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639673617","title":"CF Pharmtech files directors list with Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2639673617","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639673617?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:13","pubTimestamp":1780064009,"startTime":"0","endTime":"0","summary":"CF Pharmtech filed an updated board list with the Hong Kong Stock Exchange dated May 29, 2026.Bill Wenqing Liang remains chairperson of the board, serving as an executive director.The board comprises four executive directors, two non-executive directors, four independent non-executive directors.Audit Committee chaired by independent non-executive director Lijuan Wang; members include Jian Jin, Wang Hoi Ip.Remuneration and Appraisal Committee chaired by independent non-executive director Wang Hoi Ip; Nomination Committee chaired by independent non-executive director Shirong Wei.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the regulatory disclos","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDLcyr6L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639067356","title":"CF PharmTech non-executive director Chen Penghui resigns effective May 29, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2639067356","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639067356?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:09","pubTimestamp":1780063773,"startTime":"0","endTime":"0","summary":"CF PharmTech disclosed board and supervisory committee changes dated May 29, 2026.Non-executive director Chen Penghui resigned, effective May 29, 2026, citing other professional commitments.Supervisor and supervisory committee chair Zhang Jingjing resigned effective May 29, 2026, tied to her nomination as an executive director.Zhang, 38, has led the supervisory committee since 2021 and holds group HR and marketing management roles, including assistant general manager.Yao Zheng, 38, a capital markets and investment professional, was nominated as supervisor and supervisory committee chair; he currently chairs a private fund manager.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to ge","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL87lXpc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639673347","title":"CF Pharmtech Inc -  to Nominate Zhang Jingjing as Candidate for Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2639673347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639673347?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:09","pubTimestamp":1780063766,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nFWN4260U8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196857986","title":"CF PharmTech Repurchases 64,500 H Shares for HKD 1.29 Million, Lifts Treasury Stock to 1.17 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1196857986","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196857986?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:23","pubTimestamp":1779971012,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (HKEX: 02652) has filed a Next Day Disclosure Return detailing the on-market repurchase of 64,500 H shares on 28 May 2026. Key points are as follows: • Transaction details: Shares...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172004583","title":"CF PHARMTECH (02652) Executed HK$1.29 Million Share Buyback on May 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1172004583","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172004583?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:20","pubTimestamp":1779970828,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on May 28, 2026, the company repurchased 64,500 of its shares at a total cost of approximately HK$1.29 million.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638806655","title":"CF PharmTech Files Southeast Asia Marketing Authorization Application for Inhalation Drug; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638806655","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638806655?lang=en_us&edition=fundamental","pubTime":"2026-05-28 10:03","pubTimestamp":1779933792,"startTime":"0","endTime":"0","summary":"CF PharmTech  submitted a marketing authorization application for CF017, a budesonide suspension for inhalation, in a Southeast Asian market, according to a Thursday Hong Kong bourse filing.The drug was approved in China in 2021 and has since been commercialized in the mainland, the filing said.Shares of the company rose nearly 4% in morning trade Thursday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","02652","BK1191","CF","BK4093","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122715217","title":"CF PHARMTECH (02652): CF017 Submits Marketing Authorization Application in Southeast Asia","url":"https://stock-news.laohu8.com/highlight/detail?id=1122715217","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122715217?lang=en_us&edition=fundamental","pubTime":"2026-05-28 08:07","pubTimestamp":1779926856,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that the group has recently submitted a marketing authorization application for CF017 (Budesonide Suspension for Inhalation) to relevant drug regulatory authorities in...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","IPOS","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127781086","title":"CF PharmTech files for Southeast Asian approval of inhaled budesonide CF017, advancing global commercialization strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1127781086","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127781086?lang=en_us&edition=fundamental","pubTime":"2026-05-28 08:03","pubTimestamp":1779926595,"startTime":"0","endTime":"0","summary":"CF PharmTech (Stock Code: 02652) announced the submission of a marketing authorization application for CF017, a budesonide suspension for inhalation, to the drug regulatory authority of an unnamed...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":4,"totalSize":136,"code":"91000000","status":"200"}]}}